Drug for Cystic Fibrosis, Other Lung Diseases Reaches Successful Phase 1 End
News
Polyphor, a Swiss pharmaceutical focused on macrocycle drug discovery and development, recently announced the successful conclusion of its Phase 1 clinical testing of POL6014 for cystic fibrosis (CF), Alpha-1 Antitrypsin Deficiency (AATD), and other lung diseases. ... Read more